Quanta appointed as the ongoing Sole Tier 1 Supplier for Contract Recruitment and Technical services

The Ulverston facility will boost the UK’s drug manufacturing capability in the wake of the Covid-19 pandemic. The company aims to build on the regional and national capability to manufacture life-changing and life-saving treatments to patients globally, with supply chains currently under huge pressure to manufacture monoclonal antibodies. 

Quanta will be working to provide Lakes BioScience with contractors in all areas including (not exhaustive list) Project Management, Engineering, Project Controls, Procurement, Automation / IT, CQV and more. 

Adrian Wallis, Lakes BioScience’s Chief Strategy and Technology Officer, said:

 “The Lakes BioScience business is going to create a global CDMO which is able to be dynamic and agile in its UK manufacturing capability to meet changing market requirements. Our initial manufacturing capability will include monoclonal antibodies (mAbs) therapies, mRNA vaccines and biosimilars.

Project Apex is the first part of our overall Lakes BioScience strategy. Our intention is to invest up to £350m in a state-of-the-art manufacturing facility which uses up to 12 x 2,000-litre bioreactors.

We have made substantial progress in the feasibility, concept and basic design work and are working closely with Quanta to ensure we have a top class Client Project team to deliver the project.

This upfront investment and work enable the project to be achieved at lightning speed over an 18-month period.

Project Apex is the first part of our overall, and ambitious, strategy which ultimately will increase capability threefold with a further two buildings. This is the start of something really big and exciting.”

Quanta has been providing capital project support to the life sciences sector globally since 2002. With a global presence we have a truly international network partnering with major CAPEX projects, new product / technology introductions and operations in over 25 countries from America to Australia as well as within the UK.

If you are ready for a new role and want to be a part of this exciting project, please send your CV to our dedicated Lakes BioScience Account Director, Ben Pope, today ben.pope@quanta-cs.com. To find out more about how we support leading organisations within life sciences, contact the team today.